<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="28240">Dichloroacetate</z:chebi> (DCA) activates the <z:chebi fb="1" ids="15361">pyruvate</z:chebi> dehydrogenase complex (PDHC), and improves the recovery of cerebral pH, <z:chebi fb="4" ids="24996">lactate</z:chebi>, ATP, and PCr following reperfusion in animal models of forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In order to determine whether this results in neuroprotection, rats were administered NaDCA (100 mg/kg or 10mg/kg i.v.) 10 min before 12 min of normothermic forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> plus systemic <z:hpo ids='HP_0002615'>hypotension</z:hpo>, 45 mmHg) </plain></SENT>
<SENT sid="2" pm="."><plain>Neuronal injury assessed histopathologically 7 days post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was significantly reduced in the CA1 region of the hippocampus, the dorsal lateral striatum, and the neocortex, in rats treated with 100 mg/kg NaDCA, but not in rats treated with 10 mg/kg NaDCA </plain></SENT>
</text></document>